Author Archives: admin


Joshua Shirk continues to fight the odds; mom says God placed people where they needed to be to help him – Keyser Mineral Daily News Tribune

Mineral Daily News-Tribune

a

By Barbara High

bhigh@newstribune.info

Tribune Staff Writer

KEYSER - Monica Shirk is still holding fast to her faith - a faith that has helped see her and her family through many obstacles over what will soon be a year.

May 17, 2020, started out as any other day for the Shirks; the sun was shining and their family was together. But it would soon become the day that would forever change their lives with an event that would touch and bring together a community.

The family was out on the river in their kayaks that day. Monicas 8-year-old son Joshua was in his own kayak and was tethered to a family member. When they came upon a felled tree with a large root system in the river, however, Joshua was swept under,, becoming entangled by his life jacket in the roots. Two paramedics happened to be fishing nearby, and came to the familys aid. Approximately five to ten minutes later, Joshua was pulled from the river with no pulse. After 40 minutes of lifesaving efforts, however, Joshua once again had a pulse. Monica says she believes everything was laid out in a grand design, from those with them who pulled Joshua from the river, to the paramedics fishing nearby who werent even supposed to be on the river that day.

For Monica it was simple, God had put the right people in Joshuas path that day and has continued to do so every day since. She said that was the reason that Joshua, the boy who spent 40 minutes without life, was able to leave the hospital 30 days after entering. She also says that God continues to do so with everyone who has helped treat Joshua in the last ten months. Treatments that she says have made all the difference in Joshuas recovery.

Joshua left Ruby Memorial just 30 days after being admitted, and then spent a short time in a rehabilitation center until the Shirks were finally able to return home. That time home was short lived, however, because the path for recovery for Joshua was just beginning.

Joshua was released from the rehab center on Sept. 16, and two days later we were on our way to New Orleans, said Monica. There, they would stay for nine weeks as Joshua underwent hyperbaric oxygen therapy. Joshua would complete 41 dives in a chamber over the next nine weeks. The dives cost $12,000 for 40.

Monica said Joshua was able to have his dad in the chambers with him during the dives, when Joshua would be put in a pressurized chamber and be given different doses of pressurized air and oxygen.

The dives are designed to infiltrate the body with pure oxygenated air. Once put into the body, the air finds areas of inflammation and delivers oxygen-enriched blood, allowing the area to heal itself. For Joshua, those areas would include his brain, which had suffered swelling after the incident and is still inflamed.

Joshua will need to complete many more dives in the future. The family recently purchased a chamber for Joshua to use at home at a cost of $26,000, which was only made possible by donations they had received from a lot of wonderful people.

Monica said the cost of the dives, plus lodging and food in New Orleans, was more than the family could handle. To rent a place for a month was over $4,000 and the dives were $12,000, and that didnt include food, she said. With purchasing their own chamber, Joshua will be able to continue his dives without delay.

Joshuas doctor, Dr. Harch, will fly to the family to set up Joshuas chamber and train his family and then will oversee his care from New Orleans.

During their time in New Orleans the family was also steered towards exosmoes infusions, and with the help of his doctor, that would be the next course for the youngster.

We met other families of non-fatal drowning victims and spoke to them and they had done them, so with research and talking to the doctor, we decided to go that route, she said.

Also while in New Orleans, the family learned they would have to make the trip again.

Exosmose infusions, or Red Bull for stem cells, as his dad calls them, do kind of the same thing as his previous treatment. Joshua was injected with a tiny valve of exosmose, and although it was small, it contained about 40 billion healthy exosmoses. Once introduced to the body, they too travel to the areas of inflammation and empower them with super foods enriched with nutrients to wake up cells and tell them to work again.

Joshua also recently traveled to Arizona to undertake some stem cell therapy. There, doctors extract some fat from him after numbing him really good, in a similar procedure as liposuction. They put the specimen under a slide to check if they are rich in cells. Joshuas fat had so many healthy cells that the computer couldnt count the number and they had to wipe off the slide and put another sample back on it, said Monica.

After the fat sample is taken, it is skinned so they can separate the cells. The stem cells are then given back to Joshua. Part of the cells are given to him nasally as a mist. By doing this, the stem cells are able to cross the blood brain barrier and immediately start to work. The remainder of the stem cells are then injected at the top of the tail bone at the base of the spinal cord. There they form a sack and the excess will release from the sack and travel up the spinal column into the brain.They also begin to break off and reproduce. They stimulate the areas of inflammation and damage, which helps to get them to fire again.

Monica said the results of this treatment will become apparent after six months.

You hear people say the brain dies during times of lack of oxygen, said Monica. God in fact puts in a safeguard switch that flips to hibernation, or shuts down, if you will. Everything were doing is to shock his brain in a way to wake it back up and turn it on; to tell it to wake up and do its job.

Besides the special treatments, Joshua is also doing regular physical therapy, preparing to start occupational therapy, and speech. He is doing acupuncture as well, to help release the energy to allow the body to heal itself.The micro trauma that the needles cause sends a message of damage to the body and it releases healing properties to that area.

Everything we have done so far is using his own body to try and heal itself, said Monica. Everything we have used has been his, with the exception of the exosmose.

As far as improvements in Joshua, his mom said those have been great. Its the difference between night and day, she says. It was harder for me to see the subtle changes. I am with him 24 hours a day, but when I see the old videos, it is like, wow!

Monica says you can see the difference in her sons eyes, His pupillary responses are better and he can track better, she said. She also says his tone is better and he is so close to being able to hold his own head up.

He can retract his legs now, where before he could only extend. Plus she says there is improvement in his response time. Before, when you gave him a command, there was a larger delay in the time between when you told him to kick his legs and when he would kick his legs, she explained. That delay has gotten shorter as his brain is beginning to send messages faster.

He has also begun to do a gait trainer, which is like a walker.

Yet those are not even his biggest improvements.

Joshua started talking, Monica said. He was recently heard saying on a Facebook video while having muscle spasms, It hurts.

Hearing Joshuas voice again was music to his mothers ears. I posted the video of him talking and within hours it had 3,700 views. She sent it to her husband and told him 3,000 was other people rejoicing, and 700 was how many times she had probably watched it.

I watched it over and over again, she said. Joshua tries to talk more and more; he is always making sounds, according to his mom.

His mom says she is able to hold strong for her son because of her faith. I am doing good, she said. It was hard after coming home for the first time since the accident and having to leave just two days later. When we got home, it was also difficult to see all the reminders of Joshua from before the accident, like his medals and stuff from sports, cause he was such an athlete. I saw all this stuff of the used to be, she said.

For his mom though, it is all a matter of time. I know he will get better, this is just what is for now, this is not what is forever, she said.

Monica sees this as a marathon, not a sprint. He is not a writer, he is a fighter and doesnt give up.

My faith is stronger than ever, I think it grows a little more each day.

She isnt going to lie; there are days that are hard. Im a mother who hurts to see her child hurting, but I dont doubt my son or my God!, she says.

I knew enough medically in the beginning to know that some things were impossible medically for him, but it had to be impossible for man not for God, and to give God the glory.

Monica says that things they didnt t think could be done are now being done for Joshua through God.

The human in her sometimes says he doesnt deserve this, then she remembers that Jesus didnt deserve what happened to him. Yet he took it and all my sins, she said.

Monica says she often puts herself into Marys shoes as a mother. She watched her son get crucified for the weight of the world and I realize that is one person hears Joshuas story and comes to Christ, then its worth it. Jjust one.

As far as the future, Monica say she does see a full recovery coming. Not that I have ever doubted Joshua or God, but I had my low point in the beginning. We were at one of his doctors visits in Morgantown in the beginning, and Joshua was just laying there like he did right after the accident. He wasnt moving or anything and I told God, I need you, she recalls.

She asked God to giver her a sign. If you are going to heal my son on this earth before you return, I need a big movement. Before the doctor comes in, I need a movement, she said. As she sat staring at her son in the moment, he had been laying there staring at the wall with his face away from her. While she asked God for that sign, Joshua turned his face and looked directly at her.

I immediately asked God, If that was you, I need another sign, and Joshua, who had turned back to the wall once again, turned back to look at me.

As the doctor knocked on the door to come in, Monica said Joshua began to kick and show off his movements.

Monica says that she doesnt believe in the word normal anymore, and she is fully believing that God will give Joshua a full recovery.

His baseline I believe is going to be bigger than normal, because he is going to be whole and telling people his story, she says. He will let people know that there is hope for whatever youre going through.

Monica says there was a prayer they use to say when Joshua would go and wrestle, When times get tough, we get tougher and never give up.

He has lived that out the whole time, she says.

Joshua will continue his physical therapy, acupuncture, and occupational therapy. He also has the goal of doing blocks of 40 dives in his chamber and then rest 30 days before repeating - all of which is made possible by donations to Joshuas trust fund. The community has come together to support Joshua during this horrendous time. There had been different fundraisers for him as well, and all of this is another example of how God has put people into Joshuas life at the perfect time.

Brain and spinal injured people are written off by insurances; they only want to medicate them, Monica says. We can only afford the thing we have by donations, she added. We are so very thankful for those who have helped.

If you would like to donate for medical care for Joshua or if you would like to follow his story, you can visit Facebook at Hes fighting, Were believing.

It is the hope of Joshuas family that everyone will see the strength of God, and witness first hand what happens when God shows up!

Read the original:
Joshua Shirk continues to fight the odds; mom says God placed people where they needed to be to help him - Keyser Mineral Daily News Tribune

Global Nerve Regeneration and Repair Market Estimated To Expand At A Robust CAGR By 2026||Boston Scientific Corporation, Alafair Biosciences,…

Global nerve regeneration and repair marketis registering a healthy CAGR of 12.95% in the forecast period of 2019-2026. This rise in the market value can be attributed to high incidences of nerve injuries globally. There are various technological advancement in the nerve repair technologies. There is a surge in the number of elderly population which is driving the market growth.

The market insights of the global Nerve Regeneration and Repair market report helps with the successful launch of new product. With this report, it gets easy to attain information about customer demographics which forms the core of any business. However, it is made sure that customer information is kept secret. The report efficiently gathers, analyzes and interprets information about a market, about a product or service to be offered for sale in that market. Potential customers for the product or service and their characteristics, spending habits, location and needs of the businesss target market, the industry as a whole, and the particular competitors faced are also studied in this Nerve Regeneration and Repair report.

Download Sample PDF Copy of Reporthttps://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-nerve-regeneration-and-repair-market

Few of the major market competitors currently working in the global nerve regeneration and repair market areAxogen Corporation, Boston Scientific Corporation, Alafair Biosciences, Medtronic, Baxter, Checkpoint Surgical., Abbott, Integra LifeSciences Corporation, Nevro Corp., Orthomed (UK) Ltd, Collagen Matrix, Inc., Cyberonics, Inc., Stryker, Polyganics, LivaNova PLC, Nuvectra, NeuroPace, Inc., Allen Medical Systems, Inc., Autonomic Technologies, Inc., COOK BIOTECH, INC., Elkem ASA, GlaxoSmithKline plc, Helius Medical Technologies, The Magstim Company Ltd., TissueGen among others.

SEGMENTATION: GLOBAL NERVE REGENERATION AND REPAIRMARKET

By Product

(Neurostimulation and Neuromodulation Devices, Biomaterials),

Indication

(Failed Back Surgery Syndrome, Parkinsons disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair, Grafting),

Application

(Neurostimulation and Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting, Stem Cell Therapy),

End User

(Hospitals and Clinics, Ambulatory Surgical Centers),

Geography

(North America, South America, Europe, Asia-Pacific, Middle East & Africa)

Inquire Regarding This Reporthttps://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-nerve-regeneration-and-repair-market

Nerve Regeneration and Repair MarketScenario

According to Data Bridge Market Research the market for nerve regeneration and repair market is booming with the rising expenditure in the healthcare solutions. The climb in the ageing and maturing community globally and progress in the neurological dysfunctions encourages the business germination of nerve regeneration and repair market.

The rising demand of technological advancement and its integration with the current medical scenarios and services will shoot the growth of nerve regeneration and repair market.

Few of the restraints might hamper the market growth. Owing to the amount of cost and expenditure needed for the treatment this critical operation and to lack of trained and efficient staff to execute it will hinder the market growth in the anticipated time window. Also, major population is inclined towards the medicinal cure and therapy for nerve regeneration instead of surgical operation these factors will act as the restraint for the market development in the expected time frame of 2019 to 2026.

Now the question is which are the other regions intuitive is targeting? Data Bridge Market Research has forecasted a large growth North America, due to strong prevalence of healthcare facilities and developments or researches blooming day by day. This increment is followed by compensation feature to restore the occurred expenses which raises the chances of pocketing good revenue from nerve regeneration and repair market.

Table Of Content:

Part 01: Executive Summary Part 02: Scope Of The Report Part 03: Market Landscape

Part 04: Market Sizing

Part 05: Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape Part 08: Geographic Landscape

Part 09: Decision Framework Part 10: Drivers And Challenges

For More Insights Get Detailed TOC https://www.databridgemarketresearch.com/toc/?dbmr=global-nerve-regeneration-and-repair-market

Reasons to Purchase this Report

AboutData Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact: Data Bridge Market Research Tel: +1-888-387-2818 Email:Corporatesales@databridgemarketresearch.com

Read this article:
Global Nerve Regeneration and Repair Market Estimated To Expand At A Robust CAGR By 2026||Boston Scientific Corporation, Alafair Biosciences,...

Adult T-Cell Leukemia/Lymphoma Treatment Market 2021 Present Scenario on Growth Analysis and High Demand to 2025 KSU | The Sentinel Newspaper – KSU |…

Recently Added a New Report by Big Market Research, the 2021 growth of Adult T-Cell Leukemia/Lymphoma Treatment will have significant change from previous year. By the most conservative estimates of global Adult T-Cell Leukemia/Lymphoma Treatment market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 115.1 million in 2019. Over the next five years the Adult T-Cell Leukemia/Lymphoma Treatment market will register a 3.4% CAGR in terms of revenue, the global market size will reach US$ 131.8 million by 2025.

2021studies theGlobal Adult T-Cell Leukemia/Lymphoma Treatment Marketwith many aspects of the industry like the market size, market status, market trends, and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Market segmentation by companies, region, and type forms an integral part of this report. Historical data available in the report supports the Adult T-Cell Leukemia/Lymphoma Treatment Market development on national, regional and international levels. This is an informative study covering the Adult T-Cell Leukemia/Lymphoma Treatment Market with in-depth analysis and portraying the current state of affairs in the industry.

Ask for a Sample PDF Copy of Adult T-Cell Leukemia/Lymphoma Treatment Market with Figures, Graphs and Tocs:https://www.bigmarketresearch.com/request-sample/4172080?utm_source=KSU&utm_medium=MWA

The core objective of the business intelligence report 2021 on theAdult T-Cell Leukemia/Lymphoma TreatmentMarket is to predict the industrys performance in the upcoming years and aid stakeholders in making well-informed decisions. The study stresses on the key trends and how those can be exploited to create future opportunities. The Adult T-Cell Leukemia/Lymphoma Treatment Market is also aids in developing counter approaches for major challenges faced by the industry. In the end, we examine some inside and outside variables that drive or breaking point of the Adult T-Cell Leukemia/Lymphoma Treatment Market.

NOTE:Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

Market players have been discussed and profiles of leading players including Top Key Companies: Kyowa Kirin Daiichi Sankyo Seattle Genetics Inc. miRagen Therapeutics Celgene (Bristol-Myers Squibb) HUYA Bioscience International

Key questions answered in this report:

Talk to our Analyst / Ask for a discount on Adult T-Cell Leukemia/Lymphoma Treatment Market and Get More Information Related to This Report:https://www.bigmarketresearch.com/request-for-discount/4172080?utm_source=KSU&utm_medium=MWA

The Adult T-Cell Leukemia/Lymphoma Treatment Market is also characterized by a highly complex value chain involving product manufacturers, material suppliers, technology developers, and manufacturing equipment developers. Partnerships between research organizations and the industry players help in streamlining the path from the lab to commercialization. In order to also leverage the first mover benefit, companies need to collaborate with each other so as to develop products and technologies that are unique, innovative and cost effective.

How will this Market Intelligence Report Benefit You?

Get Access of Complete Copy of This Report and Avail Instant 10% Discount New Year Offerby Using Coupon Code [ORG123WA]:https://www.bigmarketresearch.com/checkout/sales/38016

The report includes the region-wise segmentation North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) of the market. In the regional segmentation, the regions dominating the Adult T-Cell Leukemia/Lymphoma Treatment market are included along with the regions where the growth of the market is slow.

By the product type, the Adult T-Cell Leukemia/Lymphoma Treatment Market is primarily split into 2020-2025: Chemotherapy Stem Cell Transplantation Targeted Therapy Others

By the end-users/application, the Adult T-Cell Leukemia/Lymphoma Treatment Market report covers the following segments 2020-2025: Hospitals Clinics Others

Conclusively, this report is a one stop reference point for the industrial stakeholders to get Adult T-Cell Leukemia/Lymphoma Treatment market forecast of till 2025. This report helps to know the estimated market size, market status, future development, growth opportunity, challenges, and growth drivers of by analyzing the historical overall data of the considered market segments.

You May Also Like Our Other Top Trending Reports:

For More Information Regarding Other Similar Trending Report Click on The Given Link:https://ksusentinel.com/2021/02/08/design-software-for-packaging-market-2021-global-industry-forecasts-analysis-competitive-landscape-and-key-regions-analysis/

Contact us: Mr. Abhishek Paliwal 5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States Direct:+1-971-202-1575 Toll Free:+1-800-910-6452 E-mail:help@bigmarketresearch.com

See more here:
Adult T-Cell Leukemia/Lymphoma Treatment Market 2021 Present Scenario on Growth Analysis and High Demand to 2025 KSU | The Sentinel Newspaper - KSU |...

Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels

Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients Major teaching hospital in Grenoble, France demonstrates that ePlex BCID results could have modified antimicrobial treatment in 45% of patients

Here is the original post:
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels

Arcutis Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

WESTLAKE VILLAGE, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today reported financial results for the quarter and year ended December 31, 2020, and provided a business update.

See the original post:
Arcutis Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Morphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care Conference

WALTHAM, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Praveen Tipirneni, M.D., president and chief executive officer of Morphic Therapeutic, is scheduled to participate in a panel discussion on the gastrointestinal microbiome at the 41st Annual Cowen Health Care Conference. The panel discussion will take place at 11:10 AM ET on Tuesday, March 2, 2021.

Read the original:
Morphic Therapeutic to Participate in GI/Microbiome Panel Discussion at the 41st Annual Cowen Health Care Conference

Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference

DEER PARK, Ill., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that company management will be participating in the 10th Annual SVB Leerink Global Healthcare Conference from February 24th through February 26th.

Go here to see the original:
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference

Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021

SALT LAKE CITY, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced that it will hold its quarterly earnings conference call for the period ending December 30, 2020 with investors and analysts at 4:30 p.m. EST on Tuesday, February 23, 2021. During the call, Paul J. Diaz, president and CEO, and R. Bryan Riggsbee, Chief Financial Officer, will provide a financial overview and business update of Myriad’s performance for the quarter.

Go here to read the rest:
Myriad Genetics to Announce December 2020 Quarterly Financial Results on February 23, 2021

MediWound to Report Fourth Quarter and Fiscal 2020 Financial Results and Host a Conference Call and Webcast on February 25, 2021

YAVNE, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the fourth quarter and year ended December 31, 2020 at 7:00 am Eastern Time on Thursday, February 25, 2021.

See the original post:
MediWound to Report Fourth Quarter and Fiscal 2020 Financial Results and Host a Conference Call and Webcast on February 25, 2021